Zeyang Lin

机构：Jiangsu Cancer Hospital, Shantou Central Hospital

发表论文 6 篇 · 总被引 31 次 · h-index 3

代表论文

• MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota (2023 · Frontiers in Immunology · 被引 15)
• Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy (2025 · Nature Communications · 被引 11)
• Specific MSI2 deletion maintains intestinal barrier integrity by down-regulating ILC3s-derived IL-17 a in mice with colitis (2025 · International Immunopharmacology · 被引 3)
• METTL10‐Mediated PIAS3 Methylation Links Purine Metabolism to Gastric Cancer Progression (2025 · Advanced Science · 被引 2)
• Frailty and tertiary lymphoid structures in immunosenescence: Emerging associations, mechanistic clues and future perspectives (2026 · Ageing and Cancer Research & Treatment)
• Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy (2024 · Research Square)